---
document_datetime: 2026-01-09 11:17:59
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rimmyrah-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: rimmyrah-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2826013
conversion_datetime: 2026-01-10 11:16:41.963542
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rimmyrah

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | B.II.f.1.b Extension of the shelf life of the | 09/01/2026                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000314772                     | finished product - B.II.f.1.b.5 Extension of the shelf-life of a biological/ immunological medicinal product in accordance with an approved stability protocol - Accepted   |            |                                                                                                                                                                                            |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type II / EMA/VR/0000246182 | B.II.e.1.b Change in type of container or addition of a new container - B.II.e.1.b.2 Sterile medicinal products and biological/ immunological medicinal products - Accepted | 10/07/2025 | The SmPC has been updated as follows: addition of a new presentation 'Rimmyrah 10 mg/ml solution for injection in pre-filled syringe'. The Labelling and PL have been updated accordingly. |